Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
Cover
Document And Entity Information
Financial Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (Parentheticals)
Consolidated Statements of Comprehensive Loss
Consolidated Statements of Comprehensive Loss (Parentheticals)
Consolidated Statements of Changes in Shareholders' Equity
Consolidated Statements of Changes in Shareholders' Equity (Parentheticals)
Consolidated Statements of Cash Flows
Notes to Financial Statements
General
Significant Accounting Policies
Prepaid Expenses and Other Current Assets
Short-Term Investment
Property, Plant and Equipment, Net
Other Accounts Payable
Fair Value Measurements
Revenues
Contingent Liabilities and Commitments
Shareholders' Equity
Share-Based Payment Transactions
Leases
Finance Income (Expense), Net
Taxes on Income
Transactions with Related Parties
Subsequent Events
Accounting Policies
Accounting Policies, by Policy (Policies)
Notes Tables
Significant Accounting Policies (Tables)
Prepaid Expenses and Other Current Assets (Tables)
Property, Plant and Equipment, Net (Tables)
Other Accounts Payable (Tables)
Fair Value Measurements (Tables)
Shareholders' Equity (Tables)
Share-Based Payment Transactions (Tables)
Leases (Tables)
Finance Income (Expense), Net (Tables)
Taxes on Income (Tables)
Notes Details
General (Details)
Significant Accounting Policies (Details)
Significant Accounting Policies (Details) - Schedule of property, plant and equipment
Significant Accounting Policies (Details) - Schedule of major customer data as a percentage of total revenues
Significant Accounting Policies (Details) - Schedule of outstanding share options and warrants
Prepaid Expenses and Other Current Assets (Details) - Schedule of prepaid expenses and other current assets
Short-Term Investment (Details)
Property, Plant and Equipment, Net (Details)
Property, Plant and Equipment, Net (Details) - Schedule of property, plant and equipment, net
Other Accounts Payable (Details) - Schedule of other accounts payable
Fair Value Measurements (Details) - Schedule of financial assets and liabilities measured at fair value on a recurring basis
Revenues (Details)
Contingent Liabilities and Commitments (Details)
Shareholders' Equity (Details)
Shareholders' Equity (Details) - Schedule of information regarding outstanding warrants to purchase shares
Share-Based Payment Transactions (Details)
Share-Based Payment Transactions (Details) - Schedule of expenses
Share-Based Payment Transactions (Details) - Schedule of estimated using the binomial option pricing model
Share-Based Payment Transactions (Details) - Schedule of share options, their weighted average exercise price
Leases (Details)
Leases (Details) - Schedule of lease expense and supplemental cash flow information related to leases and weighted average remaining lease terms and discount rate
Leases (Details) - Schedule of maturities of lease liabilities
Finance Income (Expense), Net (Details) - Schedule of components of finance (income)
Taxes on Income (Details)
Taxes on Income (Details) - Schedule of deferred tax assets and liabilities
Transactions with Related Parties (Details)
Subsequent Events (Details)
Significant Accounting Policies (Details) - Schedule of major customer data as a percentage of total revenues
v3.23.1
Significant Accounting Policies (Details) - Schedule of major customer data as a percentage of total revenues
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Significant Accounting Policies (Details) - Schedule of major customer data as a percentage of total revenues [Line Items]
Total revenues
100.00%
100.00%
100.00%
Cipher Pharmaceuticals [Member]
Significant Accounting Policies (Details) - Schedule of major customer data as a percentage of total revenues [Line Items]
Total revenues
11.00%
12.00%
20.00%
Chong Kun Dang Pharmaceuticals Corp [Member]
Significant Accounting Policies (Details) - Schedule of major customer data as a percentage of total revenues [Line Items]
Total revenues
25.00%
24.00%
45.00%
Gebro Holding GmBH [Member]
Significant Accounting Policies (Details) - Schedule of major customer data as a percentage of total revenues [Line Items]
Total revenues
18.00%
23.00%
35.00%
Ewopharma AG [Member]
Significant Accounting Policies (Details) - Schedule of major customer data as a percentage of total revenues [Line Items]
Total revenues
46.00%
41.00%
X
- Definition
Revenue contract with customer.
+ References
No definition available.
+ Details
Name:
canf_RevenueContractWithCustomer
Namespace Prefix:
canf_
Data Type:
dtr:percentItemType
Balance Type:
na
Period Type:
duration
X
- References
No definition available.
+ Details
Name:
canf_SignificantAccountingPoliciesDetailsScheduleofmajorcustomerdataasapercentageoftotalrevenuesLineItems
Namespace Prefix:
canf_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Details
Name:
srt_MajorCustomersAxis=canf_CipherPharmaceuticalsMember
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type:
X
- Details
Name:
srt_MajorCustomersAxis=canf_ChongKunDangPharmaceuticalsCorpMember
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type:
X
- Details
Name:
srt_MajorCustomersAxis=canf_GebroHoldingGmBHMember
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type:
X
- Details
Name:
srt_MajorCustomersAxis=canf_EwopharmaAGMember
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type: